Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
24 participants
INTERVENTIONAL
2014-11-14
2016-04-12
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Innovation in Food Production Techniques to Improve Bioactive Content
NCT02231502
Development and Validation of the Food Acceptability Questionnaire
NCT00412724
Study to Evaluate Dietary Modification in Patients With Functional Dyspepsia.
NCT02863822
The Effect of Processed Tomato Products on CVD Risks
NCT00937742
Impact of Food Process and Mastication on Nutrient Bioavailability
NCT02709837
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
A planned sample size of 20 will be recruited into the study. This study will require one initial screening visit and 5 weekly study visits. This study will take 4 weeks per subject to complete.
The trial will initiate with one screening visit which will last about 1-2 hours where the subjects' height, weight, BMI, waist circumference, fasting glucose, blood pressure and heart rate will be measured along with a survey related to general eating, health and exercise habits.
If willing and eligible to participate, a training of the online 24-hour recall software will be conducted during the screening visit. The subject will then use the software for an upcoming training week to recall foods for 3 days (2 weekdays and 1 weekend).
During the first study visit (End of Week 0) the subject will be randomly assigned an intervention sequence. The intervention sequence will dictate which intervention will be conducted for the first two weeks, leaving the second intervention for the last two weeks. Subjects will receive detailed explanation of their role and types of products they must buy during the upcoming week for the purpose of the study. They will be taught how to record on Vegetable Intake Diaries and be provided with vouchers and coupons to buy study products. They will also be given a recipe book for inspiration during the study to make appropriate meals.
The next study visits (End of Week 1-3) will take place by checking subjects' weight and then providing them with an Experience Questionnaire that is specific to their respective intervention assignment. The questionnaire will ask them to relate their study experiences over the past week. They will return any receipts and labels that were used to buy study products with the vouchers along with completed Vegetable Intake Diary. Before leaving, subjects will be provided with another set of Vegetable Intake Diaries and vouchers.
During Week 2 and 4, subjects will receive 3 surprise notifications (2 weekdays and 1 weekend) to complete the online food records. If they are unable to comply, a different day will be assigned.
The final study visit (End of Week 4) will initiate with anthropometric and vital measurements (height, weight, BMI, heart rate and blood pressure). Subject will complete Experience Questionnaire and return all receipts, labels, and diaries.
The randomization intervention sequence will be randomly assigned based on computer generated sequences. The primary difference between the intervention sequences is the order in which the subject will partake in the two intervention types. While in the tomato intervention, they will be asked to consume extra vegetable through tomato products. While in the raw intervention, however, they can only consume extra vegetables into their diet through raw vegetable products that have not been processed in any way.
Weekly Study Visits will be scheduled approximately 7 days apart.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Raw Group
Vegetables Prepared Raw (raw)
Raw
Vegetables Prepared Raw (raw).
Tomato Group
Tomato Products (tomato)
Tomato
Tomato Products (tomato)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Tomato
Tomato Products (tomato)
Raw
Vegetables Prepared Raw (raw).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Generally healthy as determined by health history questionnaire
* Weight stable
* Consume a typical western diet
* Access to grocery store with Hunt's tomato products and raw vegetable availability
* Have general cooking skills and kitchen equipped for general food preparation
* Primary shopper and food preparer in household
* Access to internet and ability to complete ASA24
* Past smokers will be allowed in the study if smoking cessation is \>1 year (preferred \> 2 years).
Exclusion Criteria
* Current vegetable intake is atypical in type or amount relative to typical American diet
* Currently dieting or taking weight loss medication or weight loss supplements
* Change in weight of more than 5% in the past month
* Special or atypical diet - e.g., vegetarian/vegan, gluten free, excessively high or low energy
* Allergic to common food(s) (dairy, soy, nut/peanut, wheat, intolerance to tomatoes)
* Have fasting blood glucose concentrations \>125 mg/dL
* Had cancer other than non-melanoma skin cancer in previous 5 yrs
* Unwilling to eat vegetables
* History of eating disorder or clinical depression as assessed by validated questionnaires.
* Presence of chronic disease or condition (e.g. diabetes, irritable bowel syndrome)
* Chronic or acute gastrointestinal disorder
* Females who are pregnant or breastfeeding
* An athlete in training or highly active person whose dietary intake is greater than average
* Investigator is uncertain about subject's capability or willingness to comply with protocol requirements
25 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Clinical Nutrition Research Center, Illinois Institute of Technology
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Britt Burton-Freeman, Ph.D
Role: PRINCIPAL_INVESTIGATOR
Illinois Institute of Technology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Clinical Nutrition Research Center
Chicago, Illinois, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB2014-090
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.